IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

GSK plc

Q4 2025 Holdings

Filed 2026-02-12 | 15 holdings | $799.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$310.2M18,245,69138.8%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$168.9M3,220,62721.1%
Biontech SE(BNTX)SPONSORED ADS09075V102$84.7M889,82410.6%
VIR Biotechnology Inc(VIR)COM92764N102$51.6M8,550,9546.5%
Lyell Immunopharma Inc(LYEL)COM NEW55083R203$46.6M1,512,6595.8%
Ideaya Biosciences Inc(IDYA)COM45166A102$46.1M1,333,3335.8%
Cytokinetics Inc(CYTK)COM NEW23282W605$21.6M340,4342.7%
Spero Therapeutics Inc(SPRO)COM84833T103$21.4M9,190,6062.7%
Fulcrum Therapeutics Inc(FULC)COM359616109$20.2M1,785,7142.5%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$10.8M1,529,5611.4%
Cvrx Inc(CVRX)COM126638105$7.2M1,007,5830.9%
Nkarta Inc(NKTX)COM65487U108$5.8M3,150,7320.7%
Regenxbio Inc(RGNX)COM75901B107$3.9M271,4560.5%
Senseonics Hldgs Inc(SENS)COM81727U303$59.9K10,8560.0%
Harvard Bioscience Inc(HBIO)COM416906105$7.5K11,1510.0%